Publicacions (27) Publicacions de ISABEL RONCERO RINCÓN

2014

  1. PAS Kinase Is a Nutrient and Energy Sensor in Hypothalamic Areas Required for the Normal Function of AMPK and mTOR/S6K1

    Molecular Neurobiology, Vol. 50, Núm. 2, pp. 314-326

2013

  1. Glucagon-Like Peptide-1 and Its Implications in Obesity

    Hot Topics in Endocrine and Endocrine-Related Diseases (IntechOpen)

  2. Insulin-Receptor Substrate-2 (IRS-2) Is Required for Maintaining Glucokinase and Glucokinase Regulatory Protein Expression in Mouse Liver

    PLoS ONE, Vol. 8, Núm. 4

  3. PAS kinase as a nutrient sensor in neuroblastoma and hypothalamic cells required for the normal expression and activity of other cellular nutrient and energy sensors

    Molecular Neurobiology, Vol. 48, Núm. 3, pp. 904-920

2012

  1. Glucagon-like peptide 1 (GLP-1) can reverse AMP-activated protein kinase (AMPK) and S6 kinase (P70S6K) activities induced by fluctuations in glucose levels in hypothalamic areas involved in feeding behaviour

    Molecular Neurobiology, Vol. 45, Núm. 2, pp. 348-361

  2. Insulin-receptor substrate-2 (IRS-2) is necessary to maintain the glucokinase and glucokinase regulatory protein expression in mouse liver

    48th EASD Annual Meeting of the European Association for the Study of Diabetes

2011

  1. Glucokinase as a Glucose Sensor in Hypothalamus - Regulation by Orexigenic and Anorexigenic Peptides

    Update on Mechanisms of Hormone Action - Focus on Metabolism, Growth and Reproduction (IntechOpen)

2009

  1. Glucokinase and glucokinase regulatory proteins are functionally coexpressed before birth in the rat brain

    Journal of Neuroendocrinology, Vol. 21, Núm. 12, pp. 973-981

2007

  1. Effects of glucose and insulin on glucokinase activity in rat hypothalamus

    Journal of Endocrinology, Vol. 193, Núm. 2, pp. 259-267

2006

  1. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability

    Biochemical Journal, Vol. 393, Núm. 1, pp. 389-396

  2. Gene symbol: GCK. Disease: diabetes, MODY.

    Human genetics, Vol. 119, Núm. 3, pp. 363

2005

  1. Substitution of the cysteine 438 residue in the cytoplasmic tail of the glucagon-like peptide-1 receptor alters signal transduction activity

    Journal of Endocrinology, Vol. 185, Núm. 1, pp. 35-44

  2. The cytoplasmic domain close to the transmembrane region of the glucagon-like peptide-1 receptor contains sequence elements that regulate agonist-dependent internalisation

    Journal of Endocrinology, Vol. 186, Núm. 1, pp. 221-231

  3. The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem

    Journal of Neurochemistry, Vol. 92, Núm. 4, pp. 798-806

2004

  1. Expression of glucose transporter isoform GLUT-2 and glucokinase genes in human brain

    Journal of Neurochemistry, Vol. 88, Núm. 5, pp. 1203-1210

2002

  1. Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain

    Journal of Neurochemistry, Vol. 80, Núm. 1, pp. 45-53

2000

  1. Functional glucokinase isoforms are expressed in rat brain

    Journal of Neurochemistry, Vol. 74, Núm. 5, pp. 1848-1857

  2. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats

    Metabolism: Clinical and Experimental, Vol. 49, Núm. 6, pp. 709-717

1998

  1. Glucagon-Like Peptide-1 (7-36) Amide as a Novel Neuropeptide Enrique Blâzquez

    Molecular Neurobiology, Vol. 18, Núm. 2, pp. 157-173

  2. Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide

    Molecular Neurobiology, Vol. 18, Núm. 2, pp. 157-173